OTC Label Multiple Columns Suggested For Elongated Packaging By CHPA
This article was originally published in The Rose Sheet
Executive Summary
FDA should allow the use of more than two columns to present required information on OTC labeling for products with long rectangular packaging, Consumer Healthcare Products Association Senior VP and Director of Science & Technology William Soller, PhD, suggested at a June 29 "feedback" meeting on the OTC labeling final rule was held in Rockville, Md.